[go: up one dir, main page]

WO2003008626A3 - Novel human nucleic acids encoding a pantothenate kinase and methods of use - Google Patents

Novel human nucleic acids encoding a pantothenate kinase and methods of use Download PDF

Info

Publication number
WO2003008626A3
WO2003008626A3 PCT/US2002/022952 US0222952W WO03008626A3 WO 2003008626 A3 WO2003008626 A3 WO 2003008626A3 US 0222952 W US0222952 W US 0222952W WO 03008626 A3 WO03008626 A3 WO 03008626A3
Authority
WO
WIPO (PCT)
Prior art keywords
disclosed
methods
pantothenate kinase
pank
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/022952
Other languages
French (fr)
Other versions
WO2003008626A2 (en
Inventor
Susan J Hayflick
Jane Gitschier
Bing Zhou
Shawn Westaway
Barbara Levinson
Monique Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon Health and Science University
University of California Berkeley
University of California San Diego UCSD
Original Assignee
Oregon Health and Science University
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon Health and Science University, University of California Berkeley, University of California San Diego UCSD filed Critical Oregon Health and Science University
Priority to AU2002326412A priority Critical patent/AU2002326412A1/en
Publication of WO2003008626A2 publication Critical patent/WO2003008626A2/en
Publication of WO2003008626A3 publication Critical patent/WO2003008626A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01033—Pantothenate kinase (2.7.1.33)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Several substantially purified pantothenate kinase polypeptides are disclosed, as are polyclonal and monoclonal antibodies that specifically bind a pantothenate kinase. Isolated polynucleotides encoding these polypeptides are also disclosed. Vectors including these polynucleotides, and host cells transfected with these polypeptides, are also disclosed herein. Methods are also disclosed herein for treating a neurodegenerative disorder by administering a PANK polynucleotide or a PANK polypeptide to a subject. Pharmaceutical compositions are further disclosed herein that include a PANK polynucleotide or polypeptide. Methods of predicting a predisposition to, or severity of, a neurodegenerative disorder are also disclosed, as are kits useful for this detection. Also disclosed herein are methods of treating a neurodegenerative disorder in a subject.
PCT/US2002/022952 2001-07-20 2002-07-19 Novel human nucleic acids encoding a pantothenate kinase and methods of use Ceased WO2003008626A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002326412A AU2002326412A1 (en) 2001-07-20 2002-07-19 Novel human nucleic acids encoding a pantothenate kinase and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30708101P 2001-07-20 2001-07-20
US60/307,081 2001-07-20
US30805501P 2001-07-25 2001-07-25
US60/308,055 2001-07-25

Publications (2)

Publication Number Publication Date
WO2003008626A2 WO2003008626A2 (en) 2003-01-30
WO2003008626A3 true WO2003008626A3 (en) 2003-10-30

Family

ID=26975528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/022952 Ceased WO2003008626A2 (en) 2001-07-20 2002-07-19 Novel human nucleic acids encoding a pantothenate kinase and methods of use

Country Status (2)

Country Link
AU (1) AU2002326412A1 (en)
WO (1) WO2003008626A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1976877T5 (en) 2005-11-30 2017-09-29 Abbvie Inc Monoclonal antibodies against amyloid beta protein and uses thereof
EP2603524A1 (en) 2010-08-14 2013-06-19 AbbVie Inc. Amyloid-beta binding proteins
BR112014026817A2 (en) 2012-04-27 2017-07-18 Retrophin Inc pantothenate derivatives for the treatment of neurological disorders
US9896464B2 (en) 2013-10-25 2018-02-20 Retrophin, Inc. Pantothenate derivatives for the treatment of neurological disorders
EP2868662A1 (en) * 2013-11-04 2015-05-06 Acies Bio d.o.o. Stable pantetheine derivatives for the treatment of pantothenate kinase associated neurodegeneration (pkan) and methods for the synthesis of such compounds
JP2019504000A (en) 2015-12-08 2019-02-14 レトロフィン， インコーポレイテッド Cyclic phosphates and cyclic phosphoramidates for the treatment of neurological disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KAWAI ET AL.: "Functional annonation of a full-length mouse cDNA collection", NATURE, vol. 409, 8 February 2001 (2001-02-08), pages 685 - 690, XP002952962 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US9540432B2 (en) 2005-11-30 2017-01-10 AbbVie Deutschland GmbH & Co. KG Anti-Aβ globulomer 7C6 antibodies
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US9359430B2 (en) 2006-11-30 2016-06-07 Abbvie Inc. Abeta conformer selective anti-Abeta globulomer monoclonal antibodies
US9394360B2 (en) 2006-11-30 2016-07-19 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins

Also Published As

Publication number Publication date
WO2003008626A2 (en) 2003-01-30
AU2002326412A1 (en) 2003-03-03

Similar Documents

Publication Publication Date Title
WO2000058473A3 (en) Nucleic acids including open reading frames encoding polypeptides; 'orfx'
WO2004035537A8 (en) Antibodies that bind cell-associated ca 125/o772p and methods of use thereof
WO2001055327A8 (en) Nucleic acids, proteins, and antibodies
WO2001054472A8 (en) Nucleic acids, proteins, and antibodies
WO2001055306A3 (en) Nucleic acids, proteins, and antibodies
WO2003008626A3 (en) Novel human nucleic acids encoding a pantothenate kinase and methods of use
WO2001036645A3 (en) Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
WO2004048521A3 (en) Composition and method for treating lupus nephritis
WO2000053742A3 (en) Polynucleotides and proteins encoded thereby
WO2002066647A3 (en) Type 2 ctokine receptor and nucleic acids encoding same
WO2001074856A3 (en) Wnt-7b-like polypeptides and nucleic acids encoding same
WO2001055168A8 (en) Nucleic acids, proteins and antibodies
WO2003025147A3 (en) Novel polynucleotides and proteins encoded thereby
WO2000061754A3 (en) Human proteins and polynucleotides encoding them
WO2001044473A3 (en) Polypeptides and nucleic acids encoding same
WO2000070046A3 (en) Secreted polypeptides and corresponding polynucleotides
WO2003040345A3 (en) Type 2 cytokine receptor and nucleic acids encoding same
WO2000003687A3 (en) Potassium channel polypeptide and polynucleotide compositions
WO2001036644A3 (en) Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
WO2003042370A3 (en) New gene expressed in prostate cancer and methods of use
WO2001057087A3 (en) High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same
WO2001051632A3 (en) Odorant receptor polypeptides and nucleic acids encoding same
WO2004047740A3 (en) Composition and method for treating lupus nephritis
WO2001055167A8 (en) Nucleic acids, proteins, and antibodies
WO2001018208A3 (en) Interferon induced polynucleotides and proteins encoded thereby

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP